Rapid Glioma Analysis Could Help Guide Brain Tumor Surgery

• October 8, 2026

2026 ASCO Breast Cancer Highlights: PANKU-Breast02

Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD discuss new results from the PANKU-Breast02 Study on a new dual-antibody drug conjugate, called izalontamab brengitecan (iza-bren), for metastatic triple-negative breast cancer.

• October 15, 2026

• 1 min

Nipple or skin-sparing mastectomy flap: can preoperative breast-MRI predict post-operative complications?

• by L. I. Sgaramella, A. Pasculli, F. P. Prete, F. Cofone, M. Moschetta, M. Maruccia, R. Elia, M. Telegrafo, V. De Ruvo, M. Bisceglie, M. M. Miccoli, F. Palma, C. Testini, G. Giudice, M. Testini, A. Gurrado

• October 13, 2026

Parents’ Perspectives on Using Computerized Cognitive Training to Manage Cognitive Late Effects in Children With Cancer: Qualitative Descriptive Study

• by Tao Liu, Lin Mo, Feisal Hasen, Shishuang Zhou, Cho Lee Wong, XueMei Tang, Ting Han

• October 13, 2026